COMPANY
Company
Leadership
Partnership & Collaboration
Location
TECHNOLOGY
Platform Technology
PIPELINE
Pipeline
Cancer Stemness Blocking Agents
IBD Therapeutic Agents
3rd Generation Immuno-Therapeutic Agents
IR/PR
News
Notice
IR
Careers
Talents
Join us
CONTACT US
ENG
ENG
KOR
COMPANY
Company
Leadership
Partnership & Collaboration
Location
TECHNOLOGY
Platform Technology
PIPELINE
Pipeline
Cancer Stemness Blocking Agents
IBD therapeutics
3rd Generation Immuno-Therapeutic Agents
IR/PR
News
Notice
IR
Careers
Talents
Join us
COMPANY
Company
Leadership
Partnership & Collaboration
Location
TECHNOLOGY
Platform Technology
PIPELINE
Pipeline
Cancer Stemness Blocking Agents
IBD therapeutics
3rd Generation Immuno-Therapeutic Agents
IR/PR
News
Notice
IR
Careers
Talents
Join us
Company
Company
Company
Leadership
Partnership & Collaboration
Location
Vision
Drugging the Undruggables
Platform technology
Drugging Informatics™
R&D
Continuous generation of first-in-class therapeutics
Vision
MISSION
Continuous generation
of first-in-class
therapeutics
GOAL
2025
Proof-of-concept
in human
GOAL
2030
New drug approval
History
Better World with
Innovative Medicine
2023
12
Selected as an “Overseas Marketing Business Task” with government grants
12
Selected as the top 10 best projects among 347 tasks in the National New Drug Development Project
11
Won bronze medal at KIT Technology Commercialization Investment Promotion Contest
2022
09
PCT (Patent Cooperation Treaty) registered in 10 countries
08
Domestic patent registration
06
Selected as a “SME technology innovation development project (market expansion type)” with government grants
03
Selected as a “Discovery of Lead materials ” with government grants
2021
11
Selected as a “Discovery of non-Clinical” with government grants
2020
12
Certified as a Inno-biz company
09
Selected as a “TIPS start-up” with government grants
07
Selected as a “BIG3 innovative company” with government grants
04
Selected as a recipient of “One-Stop Supporting Grant” of government
2019
10
VC funding
2018
11
Certified as a “Venture Company” from government
01
Selected as a recipient of “Biocore Facility Program Grant” of government
2017
04
Received certification for “Qualified R&D Institute”
from government
03
Established